戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Egr-1 (early growth response gene-1) is an immediate ear
2                                              Egr-1 and Sp1 binding site inactivation or Egr-1 and Sp1
3                                              Egr-1 bound to the GC-rich SPUR activation element in th
4                                              Egr-1 exhibited marked induction in livers of SHP-/- mic
5                                              Egr-1 increased the transcription of HB-EGF (epidermal g
6                                              Egr-1 is a master transcription factor mediating the exp
7                                              Egr-1 is a potential therapeutic target for AD.
8                                              Egr-1 is an inducible transcription factor that recogniz
9                                              Egr-1 mRNA and protein were transiently induced by HNF4a
10                                              Egr-1 null mice were protected from diet-induced obesity
11                                              Egr-1 promoter was activated by E2F1, and the activation
12                                              Egr-1 regulates tau phosphorylation and Abeta synthesis
13                                              Egr-1 silencing also reduces levels of beta-secretase 1
14                                              Egr-1 silencing does not affect levels of cyclin-depende
15                                              Egr-1 was up-regulated by IGFBP-5 in a MAPK-dependent ma
16                                              Egr-1, Egr-2, Vitamin D Receptor, MafB/c: Fos and PU.1:i
17 xpression of early growth response factor 1 (Egr-1), a master transcription factor that regulates the
18 ivity of the early growth response factor 1 (Egr-1).
19 ctivation of early growth response factor 1 (Egr-1).
20 ption factor early growth response factor 1 (Egr-1).
21 ction of the early growth response factor-1 (Egr-1) DNA-binding protein.
22 ulation of the early growth response gene-1 (Egr-1), an apparent negative transcriptional factor for
23 ne product, early growth response protein 1 (Egr-1), to examine the functional role of these vasopres
24  for genes encoding early growth response 1 (Egr-1) (transcriptional regulator), cyclooxygenase 2 (CO
25 was localized to an early growth response 1 (Egr-1) and Sp1 overlapping binding site.
26                     Early growth response 1 (Egr-1) protein is a critical regulator of genes contribu
27 ranscription factor early growth response 1 (Egr-1) regulates various vascular pathologies and is up-
28 ranscription factor early growth response 1 (Egr-1) when compared with the WT.
29 tween activation of early growth response-1 (Egr-1) and atherosclerosis and also has demonstrated tha
30 ranscription factor early growth response-1 (Egr-1) and enhanced induction of genes encoding the Egr-
31 on the induction of early growth response-1 (Egr-1) and phosphorylation of c-Jun--known mediators of
32 that RAGE regulates early growth response-1 (Egr-1) expression in hypoxia-exposed macrophages.
33                     Early growth response-1 (Egr-1) is overexpressed in human prostate tumors and con
34 ranscription factor early growth response-1 (Egr-1) mediates the stimulation of collagen transcriptio
35  in turn, regulates early growth response-1 (Egr-1), a transcription factor of mPGES-1.
36 ess including Elk1, early growth response-1 (Egr-1), and CREB.
37 ade involving E2F1, early growth response-1 (Egr-1), nuclear receptor small heterodimer partner (SHP,
38 omplexes identified early growth response-1 (Egr-1).
39  for the transcription factors ATF-2, Ets-1, Egr-1 and SP1/SP3.
40  of ASMCs(Des-/-) hypertrophy by the Erk-1/2/Egr-1/miR-26a/GSK-3beta pathway is consistent in human r
41 f the five selected genes-CD25 (IL-2Ralpha), Egr-1, Fosl-1, SOCS3, and Irf-4-was confirmed at the pro
42                                     Aberrant Egr-1 expression is implicated in carcinogenesis, inflam
43 n of HNF4alpha using siRNA largely abrogated Egr-1 promoter activation.
44                Interestingly, E2F1 activated Egr-1 expression in a biphasic fashion as described in b
45 y we use a second marker for brain activity, Egr-1, and evaluate multiple brain regions.
46    In cells containing altered p53 activity, Egr-1 expression was abolished by pharmacological inhibi
47 BD proteins can block them and thereby allow Egr-1 to avoid sequestration in non-functional locations
48 reover, IGFBP-5 induced cell migration in an Egr-1-dependent manner.
49  immediate early genes (IEGs) Arc/Arg3.1 and Egr-1 in the lateral amygdala (LA) and impairs the 'cons
50 expression of transcription factors Sp-1 and Egr-1.
51 e in the gene encoding p204 bound Egr-1, and Egr-1 activated p204 expression.
52 xtracellular signal-regulated kinase 1/2 and Egr-1 appears to be involved in the increased expression
53 on and transcription repression of Bcl-2 and Egr-1, which are downstream targets of ATF5 in C6 and U8
54 ctor (BDNF), a known inducer of DARPP-32 and Egr-1 expression, enhanced Egr-1 binding to H10 in vitro
55 xhibit significantly less ERK activation and Egr-1 expression in both bone marrow and testis in respo
56 ROS level, downregulated JNK activation, and Egr-1 expression in H9c2 cells after H/R.
57 e H/R-induced ROS level, JNK activation, and Egr-1 expression in H9c2 cells in a dose-dependent manne
58 and Sp1 mRNA and nuclear protein content and Egr-1 and Sp1 protein-DNA binding complex formation.
59  cell development, including Pax-5, E2A, and Egr-1, are reduced, while Id1 and Id2 are increased in F
60 Egr-1 by TGF-beta in normal fibroblasts, and Egr-1 was required for stimulation of collagen by Bcr-Ab
61 sion of immediate early genes like c-fos and Egr-1 by the disease mutants.
62 mory-related immediate early genes c-Fos and Egr-1 were normalized or upregulated in hippocampal CA1
63                           Both HNF4alpha and Egr-1 expression were dramatically increased in SHP(-/-)
64 ion of mitogen-activated protein kinases and Egr-1 pathways, culminating ultimately into increased ex
65 crease in PKCepsilon promoter methylation at Egr-1 and Sp-1 binding sites, leading to PKCepsilon gene
66                      The interaction between Egr-1 and H10 was confirmed in vitro and in vivo by supe
67 on may involve competitive interplay between Egr-1, YB-1, and Smads.
68                  Blocking Cdk5 action blocks Egr-1-induced tau phosphorylation but has no effect on B
69 knockdown of BACE-1 almost completely blocks Egr-1-induced amyloidogenic APP processing and Abeta syn
70 ing BACE-1 action, on the other hand, blocks Egr-1-induced amyloidogenic APP processing but does not
71 ow that ERK1/2 activity is required for both Egr-1 and CREB DNA binding to their cognate sequences id
72                               Moreover, both Egr-1 mRNA and protein were elevated in explanted sclero
73 t a sequence in the gene encoding p204 bound Egr-1, and Egr-1 activated p204 expression.
74  LPA-induced gene regulation as evidenced by Egr-1 expression.
75          We demonstrate that in COS-7 cells, Egr-1 binds to the BACE-1 promoter and activates BACE-1
76 AMP-response element-binding protein (CREB), Egr-1, and Sp1 transcription factors and that CREB-bindi
77 hows that in prostate cell lines in culture, Egr-1 overexpression correlated with an alteration of p5
78 nase (MAPK) are essential for ATF5-dependent Egr-1 activation and cell proliferation and survival.
79 k-1 phosphorylation abrogates ATF5-dependent Egr-1 activation and cell proliferation and survival.
80 r (U0126) pretreatment, and by knocking down Egr-1.
81 d by TGF-beta, which was sufficient to drive Egr-1 transactivation.
82 nversely, knockdown of SHP by siRNA elevated Egr-1 protein.
83 r of DARPP-32 and Egr-1 expression, enhanced Egr-1 binding to H10 in vitro.
84 differentiation via modulation of a Mek1/Erk/Egr-1 regulatory axis may be useful in designing new the
85       Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhi
86  suggest that the domain dynamics facilitate Egr-1's intersegment transfer that involves transient br
87 ved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of prof
88  of the early-immediate transcription factor Egr-1 in situ without also blocking the activation of Sm
89 f the major inducers of transcription factor Egr-1 in the hippocampus.
90 n (I/R) injury, and the transcription factor Egr-1 is a master switch for various damage pathways dur
91 pede association of the transcription factor Egr-1 with its targets.
92           The inducible transcription factor Egr-1, which recognizes a 9-bp target DNA sequence via t
93 e up-regulation of the transcription factors Egr-1 and c-Fos and the correlated synthesis of key proi
94 -LO expression via the transcription factors Egr-1 and CREB.
95 MT gene activation and transcription factors Egr-1 and Sp1 in adrenal medulla-derived PC12 cells.
96 etrical roles of the zinc finger domains for Egr-1 to scan DNA efficiently in the nucleus.
97 sion, our study revealed control network for Egr-1 expression through a feedback loop between SHP and
98                         JNK2 is required for Egr-1 induction.
99 phorylation of CBP at Ser436 is required for Egr-1 to activate Lhb expression and is a requirement fo
100  these studies suggest an important role for Egr-1, which, by repressing FOXC2 expression, promotes e
101  together, these data reveal novel roles for Egr-1 as a negative regulator of both CCl(4)-induced hep
102 decoy oligodeoxyribonucleotides specific for Egr-1 and CREB, we discovered that Egr-1 and CREB are di
103 gnificantly reduced vascular transcripts for Egr-1 and matrix metalloproteinase (MMP)-2 antigen and a
104 e in vitro observations, induction of c-Fos, Egr-1, and BDNF was attenuated in the D1 cortical barrel
105 ction of immediate early genes (IEGs) c-Fos, Egr-1, and Homer 1a in the amygdala and the nucleus accu
106 tivation of ERK and the expression of c-Fos, Egr-1, Arc, and brain-derived neurotrophic factor (BDNF)
107 cular dynamics (MD) simulations for the free Egr-1 and the Egr-1-DNA complex.
108                          In fibroblasts from Egr-1 knockout mice, induction of fibronectin by IGFBP-5
109 with nuclear translocation of the early gene Egr-1 In conclusion, specific and strictly ordered epige
110 eport activation of the immediate-early gene Egr-1 in the lateral amygdala (LA), hippocampus (CA1), a
111 lving activation of the immediate early gene Egr-1.
112              The early growth response gene (Egr-1) codes for a zinc finger transcription factor that
113  via EP(4) activated the EGFR --> ERK1/2 --> Egr-1 pathway, leading to increased Id-1 transcription a
114                                 However, how Egr-1 mediates the NMDAR signal in neurons has remained
115              Together, this study identifies Egr-1 as a transcriptional activator of the Ppp1r1b gene
116  in certain TGF-beta responses, and identify Egr-1 as a target of inhibition by imatinib.
117  antibody specific for PDGF-BB as well as in Egr-1(-/-) mice.
118 in these organs, were markedly attenuated in Egr-1 null mice.
119 ned by the increase of energy expenditure in Egr-1 null mice.
120 ibroblasts was accompanied by an increase in Egr-1 and YB-1 repressor binding, suggesting that the mo
121 ls undergo proliferation with an increase in Egr-1 message.
122 auses a time- and dose-dependent increase in Egr-1 protein and mRNA levels and enhanced transcription
123 pecific predator odour leads to increases in Egr-1 expression in the AON in a subregion specific mann
124 rom primary and secondary lymphoid organs in Egr-1(-/-) mice.
125 duction of the PNMT promoter and the rise in Egr-1, Sp1 and PNMT mRNA and protein.
126 fibrotic response was profoundly worsened in Egr-1-deficient mice.
127 -/-) cells; thus, these genes, which include Egr-1 and Egr-2, represent candidate mediators of positi
128 esence of competitor DNA duplexes, including Egr-1 decoys.
129 and several transcription factors, including Egr-1, AP-1, ATF-2, and NF-kappaB.
130 ted, wild-type Ras was described to increase Egr-1 transcription factor expression.
131                       In addition, increased Egr-1 expression was observed in idiopathic PAH lungs.
132 ma in the mouse was accompanied by increased Egr-1 accumulation in lesional fibroblasts.
133 d context conditioning selectively increased Egr-1 in CA1.
134 oprecipitation assay, which showed increased Egr-1 binding to the HIF-1alpha promoter in response to
135 m patients with scleroderma showed increased Egr-1 levels, which were highest in early diffuse diseas
136 te shock training, Pre rats showed increased Egr-1 mRNA in the prelimbic mPFC relative to Alt-Pre rat
137                 Common significant increased Egr-1 responses to NT (relative to vehicle) were found i
138                            Hypoxia increases Egr-1 and Sp1 mRNA and nuclear protein content and Egr-1
139 wever, only exposure to a juvenile increases Egr-1 expression in AON vasopressin neurons.
140                                      Indeed, Egr-1 was both sufficient and necessary for p300 regulat
141 ifferent mutants of p53 were shown to induce Egr-1.
142 2 inactivation and decreased IGFBP-3-induced Egr-1 expression block the autocrine and paracrine loops
143 onoxide donor; CORM-2) blocked hemin-induced Egr-1 expression.
144                           15(S)-HETE induced Egr-1 expression in a time-dependent manner in human der
145                           15(S)-HETE-induced Egr-1 expression requires Src activation.
146                            Histamine-induced Egr-1 expression is dependent on the activation of the H
147 t not p38 and JNK, mediate histamine-induced Egr-1 expression.
148 ut not p38 MAPK, is required for LPA-induced Egr-1 expression in smooth muscle cells.
149 lar signaling pathway leading to LPA-induced Egr-1 expression.
150 histone H4 acetylation, and that PMA induced Egr-1 and ATF-2 binding to the ACE promoter, whereas Ets
151     Our findings indicate that IL-13 induces Egr-1 nuclear accumulation and CREB serine phosphorylati
152       Histamine markedly and rapidly induces Egr-1 mRNA and protein expression in primary human aorti
153         The JNK inhibitor SP600125 inhibited Egr-1 overexpression in H9c2 cells caused by H/R.
154                                     Instead, Egr-1 transcription was driven by the ERK1/2 pathway, as
155                               Interestingly, Egr-1 mRNA exhibited diurnal fluctuation, which was sync
156             F2 regulates H/R-induced ROS/JNK/Egr-1 signaling, which might be an important mechanism b
157 ther there is abnormal intracellular ROS/JNK/Egr-1 signaling.
158 g was impaired, and skin fibroblasts lacking Egr-1 showed reduced migration and myofibroblast transdi
159 we show that the hippocampus of mice lacking Egr-1 displays electrophysiology properties and ultrastr
160 or basal regulation of EPO via AT1R-mediated Egr-1 activation by p21Ras-mitogen-activated protein kin
161 E-induced angiogenesis requires Src-mediated Egr-1-dependent rapid induction of FGF-2.
162                          In the LA and mPFC, Egr-1 increased to a similar extent in no shock, immedia
163 dy provides a new therapeutic target, namely Egr-1, for attenuation of elevated leukotriene levels in
164 ion of DARPP-32, whereas a dominant-negative Egr-1 blocked DARPP-32 induction by BDNF.
165 tor, and overexpression of dominant-negative Egr-1 blocked EPO promoter activation by Ang II.
166              In hippocampal primary neurons, Egr-1 binds to BACE-1 and p35 promoters, enhances tau ph
167                                     Notably, Egr-1 levels, similar to IGFBP-5, were increased in vivo
168  in the fibrotic response, delineate a novel Egr-1-dependent intracellular signaling mechanism that u
169 in kinases and reduced the levels of nuclear Egr-1 protein and phosphorylated ATF-2.
170  MAPK signaling and the induction of nuclear Egr-1 that interacts with IGFBP-5 and promotes fibrotic
171  replication is by repressing the ability of Egr-1 (early growth response-1) to bind and activate the
172 Our studies revealed sustained activation of Egr-1 with subsequent induction of its downstream target
173 ed the phosphorylation of ERK, activation of Egr-1, and expression of TNF-alpha in macrophages treate
174 ed blood flow, tissue hypoxia, activation of Egr-1, PTEN; increased caspases; and reduced survivin.
175  LPS to increase the DNA binding activity of Egr-1 and p65.
176  pathway and is dependent on the activity of Egr-1 upon the BAG3 promoter.
177 f the specific complex indicated that all of Egr-1's three zinc fingers are equally involved in bindi
178                               The binding of Egr-1 to HIF-1alpha promoter was corroborated by electro
179 cription was mediated by enhanced binding of Egr-1 to the Id-1 promoter.
180 precipitation assays demonstrated binding of Egr-1 to the PDGF-B promoter.
181 ipitation assays demonstrated the binding of Egr-1, but not Egr-3, to the Arc promoter.
182                                  Blockade of Egr-1 via forced expression of its dominant-negative mut
183 nduced activation of MAPKs and expression of Egr-1 are dependent on PKC activation.
184 g to acetylation and prolonged expression of Egr-1 in hyperglycemic conditions.
185 dence that histamine regulates expression of Egr-1 in mammalian cells and demonstrate a novel role of
186                                Expression of Egr-1 in these cells rescued the extracellular matrix-pr
187 mechanism controls LPA-induced expression of Egr-1 in vascular smooth muscle cells.
188 on, acetylation, and prolonged expression of Egr-1 leading to proinflammatory and prothrombotic respo
189 nd JNK and blocked LPA-induced expression of Egr-1 mRNA and protein.
190  activation, and increased the expression of Egr-1 protein in H9c2 cells.
191                        Ectopic expression of Egr-1 restored positive selection in SAP-1 null thymocyt
192 lleling the upregulated tissue expression of Egr-1 that accompanies fibrosis.
193 eover, we observed that tissue expression of Egr-1 was elevated in patients with scleroderma, which s
194 orrelated with increased local expression of Egr-1.
195 athway, which led to increased expression of Egr-1.
196  mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retai
197  activity was necessary for the induction of Egr-1 by TGF-beta in normal fibroblasts, and Egr-1 was r
198 lular regulatory mechanism: LPA induction of Egr-1 expression is via LPA cognate receptor (LPA recept
199 r-ss showed rapid and transient induction of Egr-1.
200 ation, we have also investigated kinetics of Egr-1's translocation between two nonspecific DNA duplex
201                                 Knockdown of Egr-1 in rat hippocampal primary neurons blocks NMDAR-in
202                                 The level of Egr-1/NGFI-A was decreased in Fgf2 KO mice and was reest
203                  Unexpectedly, the levels of Egr-1 mRNA and protein were highly up-regulated in Hnf4a
204               The mRNA and protein levels of Egr-1, a transcription factor, were increased by TNF-alp
205 of function or loss of function mutations of Egr-1.
206                  Moreover, overexpression of Egr-1 in primary striatal neurons induced the expression
207                  Likewise, overexpression of Egr-1 in rat hippocampal primary neurons causes reductio
208 ppocampal primary neurons, overexpression of Egr-1 induces BACE-1 expression, activates BACE-1, promo
209               Furthermore, overexpression of Egr-1 led to increased promoter activities for both HIF-
210 ssion rapidly via Src-mediated production of Egr-1.
211  site and within the gene promoter region of Egr-1 (early growth response protein 1) specifically in
212 IP-2, IL-17A did not affect up-regulation of Egr-1 by TCA, indicating that IL-17A does not affect bil
213 a novel role of PKCdelta in up-regulation of Egr-1 expression.
214 vealed that hypoxia-induced up-regulation of Egr-1 is mediated by RAGE signaling.
215 sential for hypoxia-stimulated regulation of Egr-1, at least in part through protein kinase C betaII,
216 ) betaII is a critical upstream regulator of Egr-1 in response to vascular stress.
217 of EGR-1 and NAB2, the latter a repressor of Egr-1.
218 tly, these results suggest a central role of Egr-1 in histamine-induced gene expression and in histam
219 induced angiogenesis, we studied the role of Egr-1.
220          Herein, we report that silencing of Egr-1 in the hippocampus by shRNA reduces tau phosphoryl
221  mechanism that underlies the stimulation of Egr-1, demonstrate for the first time sustained Egr-1 up
222 erall, a lower sensitivity to NT in terms of Egr-1 reactivity in the maternal state was highlighted a
223 n in 3T3 cells of p204 together with that of Egr-1.
224  involves ERK1/2-mediated transactivation of Egr-1, which in turn increases the secretion of EGFR lig
225 nscription factors, whereas transcription of Egr-1 and Fosl-1 was induced by the MEK-ERK pathway.
226    In particular, the zinc finger 1 (ZF1) of Egr-1 in the nonspecific complex is mainly dissociated f
227   Egr-1 and Sp1 binding site inactivation or Egr-1 and Sp1 siRNA inhibit PNMT promoter stimulation by
228 , did not change the levels of CREB, Sp1, or Egr-1 binding to the Galphas promoter, but it induced a
229 s NDRG1 transcription through an overlapping Egr-1/Sp1 binding site that acts as a major site of posi
230 igenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-beta-driven stimulation of p300 ge
231         Collectively, these results position Egr-1 downstream of c-Abl in the fibrotic response, deli
232 Our current study of the zinc-finger protein Egr-1 (also known as Zif268) and its nuclease derivative
233 -DNA association for the zinc-finger protein Egr-1.
234 ription via early growth response 1 protein (Egr-1).
235     On the contrary, HNF4alpha siRNA reduced Egr-1 expression at both the mRNA and protein levels, an
236 gnal initiated by RAGE ligand AGEs regulates Egr-1 in a manner requiring mDia-1.
237 ream component of the ERK pathway, regulates Egr-1 expression in HAECs.
238 regulatory mechanism: histamine up-regulates Egr-1 expression in primary HAECs via the H1 receptor an
239                 Therefore, H/R activates ROS/Egr-1 signaling pathway in H9c2 cells, and JNK activatio
240 uctal gray, virgin mice showed a significant Egr-1 increase with NT (relative to vehicle), but matern
241 overlapping binding consensus sites for SP1, Egr-1, and AP-2), bases C(-71) and C(-59), and an NFkapp
242 -71) and C(-59); both Cs are part of the SP1/Egr-1-binding sites.
243 st, transgenic mice with fibroblast-specific Egr-1 overexpression showed exuberant tissue repair, wit
244         The ability of TGF-beta to stimulate Egr-1 was preserved in Smad3-null mice and in explanted
245 -1, demonstrate for the first time sustained Egr-1 up-regulation in fibrotic lesions and suggests tha
246                    Our data demonstrate that Egr-1 achieves the optimal search at physiological ionic
247                          We demonstrate that Egr-1 is a transcription repressor of the PSD-95 gene an
248          The present study demonstrates that Egr-1 mRNA expression has a complex relationship to fear
249 cific for Egr-1 and CREB, we discovered that Egr-1 and CREB are directly involved in regulating 15-LO
250                       Finally, we found that Egr-1, a protein not associated previously with either I
251                  To test the hypothesis that Egr-1 function may be partially compensated by other Egr
252                  To test the hypothesis that Egr-1 is important for B cell development, we examined B
253              Therefore, we hypothesized that Egr-1 is required for the development of hepatic fibrosi
254 in immunoprecipitation assay identified that Egr-1, AP-2, and NFkappaB bind to the promoter in HYAL-1
255 tin immunoprecipitation assays indicate that Egr-1 and Sp-1 mediate TSA-induced NAG-1 expression.
256                       Our data indicate that Egr-1 is involved in NMDAR-mediated PSD-95 down-regulati
257                       Our data indicate that Egr-1 promotes Abeta synthesis via transcriptional activ
258                   Our NMR data indicate that Egr-1 undergoes highly dynamic domain motions when scann
259                        Here we observed that Egr-1 expression in white adipose tissue (WAT) was highl
260 nal analysis of FGF-2 promoter revealed that Egr-1 binding site proximal to transcription start site
261 e results point to the fundamental role that Egr-1 plays in the regulation of transforming growth fac
262                            Here we show that Egr-1 expression is tightly regulated by nuclear recepto
263                        Findings suggest that Egr-1 and Sp1 through synergistic interaction are critic
264 tional activation of BACE-1 and suggest that Egr-1 plays role in activation of BACE-1 and acceleratio
265                        Our data suggest that Egr-1's kinetic properties are well suited for efficient
266 tivities of Cdk5 and BACE-1, suggesting that Egr-1 is a potential therapeutic candidate for the treat
267 lation in fibrotic lesions and suggests that Egr-1 has a role in the induction and progression of fib
268 tients with scleroderma, which suggests that Egr-1 may be involved in tissue repair and fibrosis.
269 These results showed for the first time that Egr-1 regulates NDRG1 transcription through an overlappi
270 lear factor 4alpha (HNF4alpha) activated the Egr-1 promoter through three DR1 response elements as id
271 sphorylated Elk-1 to the SRE, activating the Egr-1 promoter.
272                            Additionally, the Egr-1-mediated induction of HIF-1alpha and FLAP promoter
273  (MD) simulations for the free Egr-1 and the Egr-1-DNA complex.
274 and enhanced induction of genes encoding the Egr-1-regulated proinflammatory chemokines monocyte chem
275 ay in the target association process for the Egr-1 zinc-finger protein is the one involving intersegm
276                Transient transfection of the Egr-1 gene into HeLa cells also resulted in up-regulatio
277 RNA levels and enhanced transcription of the Egr-1 gene via serum response elements in normal fibrobl
278  ARE and serum response element (SRE) of the Egr-1 promoter, which facilitates binding of extracellul
279 he ATF5 response element (ARE) region of the Egr-1 promoter.
280 ing induced the nuclear translocation of the Egr-1 transcription factor, and overexpression of domina
281 e measured the target search kinetics of the Egr-1 zinc-finger protein at various ionic strengths bet
282 pp, we have studied the translocation of the Egr-1 zinc-finger protein in the target DNA association
283 accelerated the target search process of the Egr-1 zinc-finger protein.
284 ation of decoys on the search process of the Egr-1 zinc-finger protein.
285 a activity, as well as its enrichment on the Egr-1 promoter, were markedly repressed by small heterod
286 ion of E2F1, SHP, and EID1 proteins with the Egr-1 promoter, and their direct protein interactions we
287 n profile overlapped only partially with the Egr-1-regulated gene profile.
288 and that activation occurs via TLR2 or TLR4, Egr-1, and MAPK pathways.
289 t mediate ERK and JNK activation, leading to Egr-1 expression, we found that LPA-induced activation o
290 , and c-Jun N-terminal kinase (JNK) prior to Egr-1 induction.
291 ws structural and functional similarities to Egr-1, these two related early-immediate transcription f
292  wild-type p53 was not sufficient to trigger Egr-1 transcription, four different mutants of p53 were
293 n Bim promoter region, while E1A upregulated Egr-1, which was directly involved in Bim transactivatio
294 prove zinc-finger technology, which has used Egr-1 (Zif268) as a major scaffold for engineering.
295 r PlGF-mediated regulation of HIF-1alpha via Egr-1, which results in increased FLAP expression.
296 ein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or
297 aspects of the DNA-scanning process in which Egr-1 is nonspecifically bound to DNA and perpetually ch
298 e stimulation, AhR was found in complex with Egr-1 and activator protein-2, which are 2 other nuclear
299 ding protein (CBP) is known to interact with Egr-1, the major mediator of GNRH action on the Lhb gene
300 CBP at Ser436 increased the interaction with Egr-1 on the Lhb promoter, loss of this phosphorylation

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top